Find Bisoprolol Fumarate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

FDF DossiersDRUG PRODUCT COMPOSITIONS

187RELATED EXCIPIENT COMPANIES

312EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 104344-23-2, Zebeta, Bisoprolol hemifumarate, Bisoprolol monofumarate, Fondril, Maintate
Molecular Formula
C22H35NO8
Molecular Weight
441.5  g/mol
InChI Key
RZPZLFIUFMNCLY-WLHGVMLRSA-N
FDA UNII
U057CX04H0

Bisoprolol Fumarate
A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
1 2D Structure

Bisoprolol Fumarate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(E)-but-2-enedioic acid;1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propan-2-ol
2.1.2 InChI
InChI=1S/C18H31NO4.C4H4O4/c1-14(2)19-11-17(20)13-23-18-7-5-16(6-8-18)12-21-9-10-22-15(3)4;5-3(6)1-2-4(7)8/h5-8,14-15,17,19-20H,9-13H2,1-4H3;1-2H,(H,5,6)(H,7,8)/b;2-1+
2.1.3 InChI Key
RZPZLFIUFMNCLY-WLHGVMLRSA-N
2.1.4 Canonical SMILES
CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O.C(=CC(=O)O)C(=O)O
2.1.5 Isomeric SMILES
CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O.C(=C/C(=O)O)\C(=O)O
2.2 Other Identifiers
2.2.1 UNII
U057CX04H0
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Bisoprolol

2. Bisoprolol Fumarate (1:1) Salt, (+-)-isomer

3. Bisoprolol Fumarate (2:1) Salt, (+-)-isomer

4. Bisoprolol Hydrochloride

5. Bisoprolol Methanesulfonate Salt

6. Bisoprolol, (+-)-isomer

7. Bisoprolol, (-)-isomer

8. Bisoprolol, Fumarate (1:1) Salt

9. Bisoprolol, Fumarate (2:1) Salt

10. Cl 297939

11. Cl-297939

12. Cl297939

13. Concor

14. Emd 33512

15. Emd-33512

16. Emd33512

17. Fumarate, Bisoprolol

18. Hydrochloride, Bisoprolol

2.3.2 Depositor-Supplied Synonyms

1. 104344-23-2

2. Zebeta

3. Bisoprolol Hemifumarate

4. Bisoprolol Monofumarate

5. Fondril

6. Maintate

7. Concor

8. 105878-43-1

9. Bisoprolol (fumarate)

10. Bisoprolol Hemifumarate Salt

11. U057cx04h0

12. Emd33512

13. Ta-4708

14. Cl-297939

15. 1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol,(2e)-2-monobutenedioate

16. 2-propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-, (2e)-2-butenedioate (1:1)

17. 2-propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-, (2e)-2-butenedioate (1:1) (salt)

18. 2-propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-, (e)-2-butenedioate (1:1) (salt)

19. Smr000471619

20. Emd-33512

21. Bisocard

22. Cardicor

23. Congescor

24. Sr-01000597980

25. Bisoprololfumarate

26. Concor Cor

27. 66722-45-0

28. Bisoprolol Fumarate (1:x)

29. Schembl41419

30. Mls001076669

31. Mls001401436

32. Unii-u057cx04h0

33. Chembl1200708

34. Bcpp000331

35. Hms1569a21

36. Hms2051i16

37. Hms2094o19

38. Hms2233f12

39. Hms3884o05

40. Pharmakon1600-01505704

41. Nsc759181

42. S1206

43. Akos005267174

44. Ac-5016

45. Bcp9000419

46. Ccg-100883

47. Ccg-213520

48. Nc00133

49. Nsc-759181

50. Hy-120829

51. B3994

52. Cs-0079270

53. Sw197151-3

54. 104b232

55. Q-200729

56. Sr-01000597980-4

57. Q27290514

58. 1-(4-((2-isopropoxyethoxy)methyl)phenoxy)-3-(isopropylamino)propan-2-ol Hemi-fumarate

59. 1-{4-[(2-isopropoxyethoxy)methyl]phenoxy}-3-(isopropylamino)-2-propanol Fumaric Acid Salt

2.4 Create Date
2006-07-28
3 Chemical and Physical Properties
Molecular Weight 441.5 g/mol
Molecular Formula C22H35NO8
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count9
Rotatable Bond Count14
Exact Mass441.23626707 g/mol
Monoisotopic Mass441.23626707 g/mol
Topological Polar Surface Area135 Ų
Heavy Atom Count31
Formal Charge0
Complexity397
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameBisoprolol fumarate
Drug LabelBisoprolol fumarate is a synthetic, beta1-selective (cardioselective) adrenoceptor blocking agent. The chemical name for bisoprolol fumarate is ()-1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol(E)-2-butenedioate...
Active IngredientBisoprolol fumarate
Dosage FormTablet
RouteOral
Strength5mg; 10mg
Market StatusPrescription
CompanyTeva Pharms; Unichem Pharms (usa); Aurobindo Pharma; Sandoz; Mylan

2 of 4  
Drug NameZebeta
PubMed HealthBisoprolol (By mouth)
Drug ClassesAntianginal, Antihypertensive, Cardiovascular Agent
Drug LabelZEBETA (bisoprolol fumarate) is a synthetic, beta1-selective (cardioselective) adrenoceptor blocking agent. The chemical name for bisoprolol fumarate is ()-1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol(E)-2-but...
Active IngredientBisoprolol fumarate
Dosage FormTablet
RouteOral
Strength5mg; 10mg
Market StatusPrescription
CompanyTeva Womens

3 of 4  
Drug NameBisoprolol fumarate
Drug LabelBisoprolol fumarate is a synthetic, beta1-selective (cardioselective) adrenoceptor blocking agent. The chemical name for bisoprolol fumarate is ()-1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol(E)-2-butenedioate...
Active IngredientBisoprolol fumarate
Dosage FormTablet
RouteOral
Strength5mg; 10mg
Market StatusPrescription
CompanyTeva Pharms; Unichem Pharms (usa); Aurobindo Pharma; Sandoz; Mylan

4 of 4  
Drug NameZebeta
PubMed HealthBisoprolol (By mouth)
Drug ClassesAntianginal, Antihypertensive, Cardiovascular Agent
Drug LabelZEBETA (bisoprolol fumarate) is a synthetic, beta1-selective (cardioselective) adrenoceptor blocking agent. The chemical name for bisoprolol fumarate is ()-1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol(E)-2-but...
Active IngredientBisoprolol fumarate
Dosage FormTablet
RouteOral
Strength5mg; 10mg
Market StatusPrescription
CompanyTeva Womens

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Adrenergic beta-1 Receptor Antagonists

Drugs that bind to and block the activation of ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Antagonists.)


Antihypertensive Agents

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)


Sympatholytics

Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
beta-Adrenergic Blocker [EPC]; Adrenergic beta-Antagonists [MoA]

API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 35650

Submission : 2021-02-16

Status : Active

Type : II

Supriya

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMoehs Group, a reference company in the production of pharmaceutical active ingredients.

Flag Spain
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2015-09-11

Pay. Date : 2015-09-04

DMF Number : 15083

Submission : 2000-10-10

Status : Active

Type : II

Moehs Iberica

03

Arevipharma Gmbh

Germany

USDMF

arrow
AACR Annual meeting
Not Confirmed

03

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2013-12-18

Pay. Date : 2013-08-02

DMF Number : 23241

Submission : 2009-11-02

Status : Active

Type : II

blank

04

AACR Annual meeting
Not Confirmed

04

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2019-03-01

Pay. Date : 2019-01-28

DMF Number : 18781

Submission : 2005-09-12

Status : Active

Type : II

blank

05

AACR Annual meeting
Not Confirmed

05

06

Corden Pharma Chenove

Germany

USDMF

arrow
AACR Annual meeting
Not Confirmed

06

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2018-02-08

Pay. Date : 2017-10-10

DMF Number : 13910

Submission : 1998-12-22

Status : Active

Type : II

blank

07

Ipca Laboratories Ltd

India

USDMF

arrow
AACR Annual meeting
Not Confirmed

07

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 24120

Submission : 2010-12-09

Status : Inactive

Type : II

blank

08

Merck Kgaa

Germany

USDMF

arrow
AACR Annual meeting
Not Confirmed

08

Merck Kgaa

Germany
arrow
AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 8024

Submission : 1989-04-12

Status : Active

Type : II

blank

09

Taiwan Biotech Co Ltd

Taiwan

USDMF

arrow
AACR Annual meeting
Not Confirmed

09

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 20120

Submission : 2006-12-11

Status : Active

Type : II

blank

10

AACR Annual meeting
Not Confirmed

10

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 16398

Submission : 2003-01-29

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-moreread-more
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothReliable Spanish CDMO Delivering High-Quality APIs and Intermediates with Excellence, Flexibility, and Regulatory Compliance.

Flag Spain
Digital Content Digital Content
R1-CEP 2015-243 - Rev 00
Valid
Chemical
2022-02-03
1710
Kinsy SL Company Banner

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothReliable Spanish CDMO Delivering High-Quality APIs and Intermediates with Excellence, Flexibility, and Regulatory Compliance.

Flag Spain
Digital Content Digital Content

Certificate Number : R1-CEP 2015-243 - Rev 00

Status : Valid

Issue Date : 2022-02-03

Type : Chemical

Substance Number : 1710

Kinsy SL Company Banner
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMoehs Group, a reference company in the production of pharmaceutical active ingredients.

Flag Spain
Digital Content Digital Content
CEP 2009-044 - Rev 02
Valid
Chemical
2024-08-16
1710
Moehs Iberica

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMoehs Group, a reference company in the production of pharmaceutical active ingredients.

Flag Spain
Digital Content Digital Content

Certificate Number : CEP 2009-044 - Rev 02

Status : Valid

Issue Date : 2024-08-16

Type : Chemical

Substance Number : 1710

Moehs Iberica
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

Flag India
Digital Content Digital Content
R0-CEP 2020-095 - Rev 00
Valid
Chemical
2022-05-04
1710
Rusan Pharma

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

Flag India
Digital Content Digital Content

Certificate Number : R0-CEP 2020-095 - Rev 00

Status : Valid

Issue Date : 2022-05-04

Type : Chemical

Substance Number : 1710

Rusan Pharma
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothQingmu Pharma: Patients first, FDA/CEP/US-DMF/US-VMF/ASMF APIs for Humans & Vets in 100+ countries.

Flag China
Digital Content Digital Content
CEP 2016-139 - Rev 01
Valid
Chemical
2024-01-23
1710
Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothQingmu Pharma: Patients first, FDA/CEP/US-DMF/US-VMF/ASMF APIs for Humans & Vets in 100+ countries.

Flag China
Digital Content Digital Content

Certificate Number : CEP 2016-139 - Rev 01

Status : Valid

Issue Date : 2024-01-23

Type : Chemical

Substance Number : 1710

Company Banner

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Certificate Number : CEP 2007-336 - Rev 04

Status : Valid

Issue Date : 2023-12-13

Type : Chemical

Substance Number : 1710

blank

06

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Certificate Number : R1-CEP 2008-143 - Rev 01

Status : Withdrawn by Holder

Issue Date : 2018-01-29

Type : Chemical

Substance Number : 1710

blank

07

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Certificate Number : R0-CEP 2013-342 - Rev 02

Status : Withdrawn by EDQM Failure to CEP pro...

Issue Date : 2019-05-13

Type : Chemical

Substance Number : 1710

blank

08

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Certificate Number : R1-CEP 2008-287 - Rev 01

Status : Valid

Issue Date : 2023-04-24

Type : Chemical

Substance Number : 1710

blank

09

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Certificate Number : CEP 2015-127 - Rev 01

Status : Valid

Issue Date : 2024-03-05

Type : Chemical

Substance Number : 1710

blank

10

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Certificate Number : CEP 2010-344 - Rev 02

Status : Valid

Issue Date : 2024-06-03

Type : Chemical

Substance Number : 1710

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMoehs Group, a reference company in the production of pharmaceutical active ingredients.

Flag Spain
Digital Content Digital Content

Bisoprolol fumarate

Registration Number : 218MF10893

Registrant's Address : Cesar Martinell i Brunet 12A, Poligono Rubi Sur, Rubi (Barcelona), Spain

Initial Date of Registration : 2006-11-10

Latest Date of Registration : 2019-09-11

Moehs Iberica

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothQingmu Pharma: Patients first, FDA/CEP/US-DMF/US-VMF/ASMF APIs for Humans & Vets in 100+ countries.

Flag China
Digital Content Digital Content

Bisoprolol fumarate

Registration Number : 230MF10053

Registrant's Address : No. 8, Xiyuan Avenue, Hi-Tech District, Chengdu, 611731, China.

Initial Date of Registration : 2018-04-17

Latest Date of Registration : 2018-04-17

Company Banner

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Bisoprolol fumarate

Registration Number : 301MF10029

Registrant's Address : Meissner Strasse 35 D-01445 Radebeul, Germany

Initial Date of Registration : 2019-07-05

Latest Date of Registration : 2019-07-05

blank

04

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Bisoprolol fumarate

Registration Number : 224MF10091

Registrant's Address : 326 Yokamachi, Toyama City, Toyama Prefecture

Initial Date of Registration : 2012-04-25

Latest Date of Registration : 2012-04-25

blank

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Japanese Pharmacopoeia Bisoprolol Fumarate (For Manufacturing Use Only)

Registration Number : 221MF10070

Registrant's Address : 326 Yokamachi, Toyama City, Toyama Prefecture

Initial Date of Registration : 2009-04-08

Latest Date of Registration : 2009-04-08

blank

06

Merck & Cie KmG

Switzerland
AACR Annual meeting
Not Confirmed
arrow

Merck & Cie KmG

Switzerland
arrow
AACR Annual meeting
Not Confirmed

Bisoprolol fumarate

Registration Number : 220MF10126

Registrant's Address : Weisshausmatte, 6460 Altdorf UR, Switzerland

Initial Date of Registration : 2008-05-15

Latest Date of Registration : 2024-08-22

blank

07

MERCK&CIE KG

Switzerland
AACR Annual meeting
Not Confirmed
arrow

MERCK&CIE KG

Switzerland
arrow
AACR Annual meeting
Not Confirmed

Bisoprolol fumarate

Registration Number : 217MF11012

Registrant's Address : WEISSHAUSMATTE CH-6460 ALTDORF SWITZERLAND

Initial Date of Registration : 2005-11-21

Latest Date of Registration : 2006-04-27

blank

08

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Bisoprolol fumarate

Registration Number : 217MF11134

Registrant's Address : 1-10-11 Nihonbashi Horidomecho, Chuo-ku, Tokyo

Initial Date of Registration : 2005-12-05

Latest Date of Registration : 2008-07-31

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET;ORAL - 10MG **Federal Registe...DOSAGE - TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 19982

read-more

DOSAGE - TABLET;ORAL - 5MG **Federal Register...DOSAGE - TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 19982

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Direct Compression

read-more
read-more

Controlled & Modified Release

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Granulation

read-more
read-more

Solubilizers

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Topical

read-more
read-more

Lubricants & Glidants

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Taste Masking

read-more
read-more

Emulsifying Agents

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Parenteral

read-more
read-more

API Stability Enhancers

read-more
read-more

Rheology Modifiers

read-more
read-more

Empty Capsules

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Vegetarian Capsules

read-more
read-more

Coloring Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

read-more
read-more

01

arrow
AACR Annual meeting
Not Confirmed
arrow
AACR Annual meeting
Not Confirmed

Company : Advagen Pharma

Bisoprolol Fumarate

Drug Cost (USD) : 755,883

Year : 2023

Prescribers : 10439

Prescriptions : 15688

blank

02

arrow
AACR Annual meeting
Not Confirmed
arrow
AACR Annual meeting
Not Confirmed

Company : Alembic Pharmac

Bisoprolol Fumarate

Drug Cost (USD) : 2,184,932

Year : 2023

Prescribers : 12630

Prescriptions : 53043

blank

03

arrow
AACR Annual meeting
Not Confirmed
arrow
AACR Annual meeting
Not Confirmed

Company : Aurobindo Pharm

Bisoprolol Fumarate

Drug Cost (USD) : 2,290,279

Year : 2023

Prescribers : 21554

Prescriptions : 48795

blank

04

arrow
AACR Annual meeting
Not Confirmed
arrow
AACR Annual meeting
Not Confirmed

Company : Northstar Rx Ll

Bisoprolol Fumarate

Drug Cost (USD) : 3,076,025

Year : 2023

Prescribers : 20199

Prescriptions : 65797

blank

05

arrow
AACR Annual meeting
Not Confirmed
arrow
AACR Annual meeting
Not Confirmed

Company : Novitium/Ani Ph

Bisoprolol Fumarate

Drug Cost (USD) : 14,069,882

Year : 2023

Prescribers : 94764

Prescriptions : 303330

blank

06

arrow
AACR Annual meeting
Not Confirmed
arrow
AACR Annual meeting
Not Confirmed

Company : Trupharma, LLC.

Bisoprolol Fumarate

Drug Cost (USD) : 10,533,131

Year : 2023

Prescribers : 79399

Prescriptions : 213419

blank

07

arrow
AACR Annual meeting
Not Confirmed
arrow
AACR Annual meeting
Not Confirmed

Company : Unichem Pharmac

Bisoprolol Fumarate

Drug Cost (USD) : 8,645,201

Year : 2023

Prescribers : 92853

Prescriptions : 250644

blank

08

arrow
AACR Annual meeting
Not Confirmed
arrow
AACR Annual meeting
Not Confirmed

Company : Viona Pharmaceu

Bisoprolol Fumarate

Drug Cost (USD) : 2,253,107

Year : 2023

Prescribers : 38607

Prescriptions : 56494

blank

09

arrow
AACR Annual meeting
Not Confirmed
arrow
AACR Annual meeting
Not Confirmed

Company : Edenbridge Phar

Bisoprolol/Hydrochlorothiazide

Drug Cost (USD) : 8,790,980

Year : 2023

Prescribers : 55294

Prescriptions : 194120

blank

10

arrow
AACR Annual meeting
Not Confirmed
arrow
AACR Annual meeting
Not Confirmed

Company : Glenmark Pharma

Bisoprolol/Hydrochlorothiazide

Drug Cost (USD) : 1,356,808

Year : 2023

Prescribers : 10731

Prescriptions : 31336

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Regulatory FDF Prices

read-more
read-more

01

Brand Name : BISOPROLOL PENSA PHARMA

Japan
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.

Flag Japan
Digital Content Digital Content

RX/OTC/DISCN :

Bisoprolol Fumarate

Dosage Form : Tablets

Dosage Strength : 1.25 mg

Price Per Pack (Euro) : 2.41

Published in :

Country : Italy

RX/OTC/DISCN :

Towa Pharmaceutical

02

Brand Name : BISOPROLOL THINK

Japan
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.

Flag Japan
Digital Content Digital Content

RX/OTC/DISCN :

Bisoprolol Fumarate

Dosage Form : Coated Tablets

Dosage Strength : 2.5 mg

Price Per Pack (Euro) : 2.59

Published in :

Country : Italy

RX/OTC/DISCN :

Towa Pharmaceutical

03

Brand Name : BISOPROLOL THINK

Japan
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.

Flag Japan
Digital Content Digital Content

RX/OTC/DISCN :

Bisoprolol Fumarate

Dosage Form : Coated Tablets

Dosage Strength : 5 mg

Price Per Pack (Euro) : 4.48

Published in :

Country : Italy

RX/OTC/DISCN :

Towa Pharmaceutical

04

Brand Name : BISOPROLOL PENSA PHARMA

Japan
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.

Flag Japan
Digital Content Digital Content

RX/OTC/DISCN :

Bisoprolol Fumarate

Dosage Form : Tablets

Dosage Strength : 7.5 mg

Price Per Pack (Euro) : 3.37

Published in :

Country : Italy

RX/OTC/DISCN :

Towa Pharmaceutical

05

Brand Name : Sequacor

Italy
arrow
AACR Annual meeting
Not Confirmed

Brand Name : Sequacor

Italy
arrow
AACR Annual meeting
Not Confirmed

Bisoprolol Fumarate

Dosage Form : Bisoprololo 1.25Mg 28 Combined O...

Dosage Strength : 28 cpr riv 1.25 mg

Price Per Pack (Euro) : 4.57

Published in :

Country : Italy

RX/OTC/DISCN : Class A

blank

06

Brand Name : Congeor

Japan
arrow
AACR Annual meeting
Not Confirmed

Brand Name : Congeor

Japan
arrow
AACR Annual meeting
Not Confirmed

Bisoprolol Fumarate

Dosage Form : Bisoprololo 1.25Mg 28 Combined O...

Dosage Strength : 28 cpr riv 1.25 mg

Price Per Pack (Euro) : 6.63

Published in :

Country : Italy

RX/OTC/DISCN : Class A

blank

07

Brand Name : Bisoprololo

Italy
arrow
AACR Annual meeting
Not Confirmed

Brand Name : Bisoprololo

Italy
arrow
AACR Annual meeting
Not Confirmed

Bisoprolol Fumarate

Dosage Form : Bisoprololo 1.25Mg 28 Combined O...

Dosage Strength : 28 CPR 1.25 mg

Price Per Pack (Euro) : 2.41

Published in :

Country : Italy

RX/OTC/DISCN : Class A

blank

08

Brand Name : Bisoprololo

U.S.A
arrow
AACR Annual meeting
Not Confirmed

Brand Name : Bisoprololo

U.S.A
arrow
AACR Annual meeting
Not Confirmed

Bisoprolol Fumarate

Dosage Form : Bisoprololo 1.25Mg 28 Combined O...

Dosage Strength : 28 CPR 1.25 mg

Price Per Pack (Euro) : 2.41

Published in :

Country : Italy

RX/OTC/DISCN : Class A

blank

09

Brand Name : Bisoprololo

U.S.A
arrow
AACR Annual meeting
Not Confirmed

Brand Name : Bisoprololo

U.S.A
arrow
AACR Annual meeting
Not Confirmed

Bisoprolol Fumarate

Dosage Form : Bisoprololo 1.25Mg 28 Combined O...

Dosage Strength : 28 cpr riv 1.25 mg

Price Per Pack (Euro) : 2.65

Published in :

Country : Italy

RX/OTC/DISCN : Class A

blank

10

Brand Name : Bisoprololo

Country
arrow
AACR Annual meeting
Not Confirmed

Brand Name : Bisoprololo

Country
arrow
AACR Annual meeting
Not Confirmed

Bisoprolol Fumarate

Dosage Form : Bisoprololo 1.25Mg 28 Combined O...

Dosage Strength : 28 CPR 1.25 mg

Price Per Pack (Euro) : 2.41

Published in :

Country : Italy

RX/OTC/DISCN : Class A

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ANALYTICAL

Upload your methods for free, ask us

ABOUT THIS PAGE

Looking for 105878-43-1 / Bisoprolol Fumarate API manufacturers, exporters & distributors?

Bisoprolol Fumarate manufacturers, exporters & distributors 1

49

PharmaCompass offers a list of Bisoprolol Fumarate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Bisoprolol Fumarate manufacturer or Bisoprolol Fumarate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bisoprolol Fumarate manufacturer or Bisoprolol Fumarate supplier.

API | Excipient name

Bisoprolol Fumarate

Synonyms

104344-23-2, Zebeta, Bisoprolol hemifumarate, Bisoprolol monofumarate, Fondril, Maintate

Cas Number

105878-43-1

Unique Ingredient Identifier (UNII)

U057CX04H0

About Bisoprolol Fumarate

A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.

Emcor Manufacturers

A Emcor manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Emcor, including repackagers and relabelers. The FDA regulates Emcor manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Emcor API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Emcor manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Emcor Suppliers

A Emcor supplier is an individual or a company that provides Emcor active pharmaceutical ingredient (API) or Emcor finished formulations upon request. The Emcor suppliers may include Emcor API manufacturers, exporters, distributors and traders.

click here to find a list of Emcor suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Emcor USDMF

A Emcor DMF (Drug Master File) is a document detailing the whole manufacturing process of Emcor active pharmaceutical ingredient (API) in detail. Different forms of Emcor DMFs exist exist since differing nations have different regulations, such as Emcor USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Emcor DMF submitted to regulatory agencies in the US is known as a USDMF. Emcor USDMF includes data on Emcor's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Emcor USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Emcor suppliers with USDMF on PharmaCompass.

Emcor JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Emcor Drug Master File in Japan (Emcor JDMF) empowers Emcor API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Emcor JDMF during the approval evaluation for pharmaceutical products. At the time of Emcor JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Emcor suppliers with JDMF on PharmaCompass.

Emcor KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Emcor Drug Master File in Korea (Emcor KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Emcor. The MFDS reviews the Emcor KDMF as part of the drug registration process and uses the information provided in the Emcor KDMF to evaluate the safety and efficacy of the drug.

After submitting a Emcor KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Emcor API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Emcor suppliers with KDMF on PharmaCompass.

Emcor CEP

A Emcor CEP of the European Pharmacopoeia monograph is often referred to as a Emcor Certificate of Suitability (COS). The purpose of a Emcor CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Emcor EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Emcor to their clients by showing that a Emcor CEP has been issued for it. The manufacturer submits a Emcor CEP (COS) as part of the market authorization procedure, and it takes on the role of a Emcor CEP holder for the record. Additionally, the data presented in the Emcor CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Emcor DMF.

A Emcor CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Emcor CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Emcor suppliers with CEP (COS) on PharmaCompass.

Emcor WC

A Emcor written confirmation (Emcor WC) is an official document issued by a regulatory agency to a Emcor manufacturer, verifying that the manufacturing facility of a Emcor active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Emcor APIs or Emcor finished pharmaceutical products to another nation, regulatory agencies frequently require a Emcor WC (written confirmation) as part of the regulatory process.

click here to find a list of Emcor suppliers with Written Confirmation (WC) on PharmaCompass.

Emcor NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Emcor as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Emcor API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Emcor as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Emcor and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Emcor NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Emcor suppliers with NDC on PharmaCompass.

Emcor GMP

Emcor Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Emcor GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Emcor GMP manufacturer or Emcor GMP API supplier for your needs.

Emcor CoA

A Emcor CoA (Certificate of Analysis) is a formal document that attests to Emcor's compliance with Emcor specifications and serves as a tool for batch-level quality control.

Emcor CoA mostly includes findings from lab analyses of a specific batch. For each Emcor CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Emcor may be tested according to a variety of international standards, such as European Pharmacopoeia (Emcor EP), Emcor JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Emcor USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty